LSD1-IN-2
LSD1-IN-2 is a LSD1 inhibitor with an IC50 of 0.5 μM. LSD1-IN-2 increases the levels of monomethylated and dimethylated histone H3 lysine 4 (H3K4me1/2) in cells. LSD1-IN-2 reactivates epigenetically silenced tumor suppressor genes. LSD1-IN-2 can be used in the research of colon cancer.
For research use only. We do not sell to patients.
- CAS No.: 927019-63-4
- Formula: C15H36N8
- Molecular Weight:328.51
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
LSD1 0.5 μM (IC50) |
In Vitro
LSD1-IN-2 (Compound 39) potently inhibits LSD1 with an IC50 of 0.5 μM[1].
LSD1-IN-2 (0.5-10 μM) induces dose-dependent increases in H3K4me1/2 levels and tumor suppressor gene re-expression in HCT-116 colon cancer cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
CAS No. 927019-63-4
-
Molecular Weight 328.51
-
Formula C15H36N8
-
SMILES
N(=C(NC)NC)CCCNCCCNCCCN=C(NC)NC
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)